Most of the analysis I have seen is using 17 as the denominator - not the 20 number expected to be randomized into Arm D. The 17 are those receiving 1 or more treatments.
The drop rate in Arm D was much higher than in Prove 1 by the way, 4/17 vs. 11% overall.
It also appears there may be some failures with SVRs judging from the response at 12 weeks measured on an ITT-basis vs. LOC-basis. The LOC basis is significantly higher and represents using the last measurement for droppers.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.